Akebia Therapeutics, Inc.·4

Nov 3, 4:47 PM ET

FRIESON RON 4

4 · Akebia Therapeutics, Inc. · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-01
FRIESON RON
Director
Transactions
  • Award

    Stock Option (Right to buy)

    2021-11-01+80,20080,200 total
    Exercise: $3.13Exp: 2031-11-01Common Stock (80,200 underlying)
Footnotes (1)
  • [F1]The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT